Addiction and Pharmacology Research
Open Trials | Trials Coming Soon | Current ProjectsOpen Trials
| Principal Investigator/Contact Information | Protocol Title | Patient Population | Recruitment Period |
| Principal Investigator: Gantt Galloway, PharmD Contact: Jennifer Siegrist 415-641-3370 | Phase II Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence Visit this study on ClinicalTrials.gov. | Males and Females ages 18-65 that use methamphetamine and want to quit. Must be able to come in 3x per week for visits. | Open |
| Principal Investigator: Keith Flower, MD Contact: Jayme Mulkey 415 641 3370 | A Pilot Trial of Naltrexone for Methamphetamine Addiction - Role of the A118G SNP Visit this study on ClinicalTrials.gov. | Males and Females ages 18-50 that use methamphetamine and want to quit | Open |
| Principal Investigator: Linghui Li MD PhD & John Mendelson MD Contact: Linghui Li 415-641-3370 | An Open-Label Study to Evaluate the Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine in Healthy Adults | Healthy males and females ages 18-55 | Open |
Back to top
Trials Coming Soon
| Principal Investigator/Contact Information | Protocol Title | Patient Population | Recruitment Period |
| Principal Investigator: Gantt Galloway, PharmD Contact: Margie Jang, NP 415-641-3370 | A Phase 1, Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Cocaine and Lofexidine | Cocaine-experienced males and females aged 18-50 years. Must be able to be inpatient 10 nights and 11 days | Coming Soon |
| Principal Investigator: Gantt P. Galloway PharmD Contact: Jose Guillen 415 641 3370 | A Dose Ranging Study of Modafinil for Methamphetamine Dependence | Males and Females ages 18-50 that use methamphetamine and want to quit | Coming Soon |
| Principal Investigator: John Mendelson MD Contact: Jennifer Siegrist 415-641-3370 | The Effects of MDMA on Sleep Architecture, Water Homeostasis and Cognitive Function: Acute and 24-48 hour Post Dose Discontinuation Effects | MDMA-experienced males and females aged 18-50 years | Coming Soon |
updated: 11/09/09
Back to top

